News and Updates

A historic CAR-T approval for solid tumors and a $10B Pfizer-Innovent pact signal a new era of global oncology innovation and strategic biopharma growth.

The CHMP has recommended the approval of Jaypirca (pirtobrutinib) for adults with chronic lymphocytic leukemia. Learn about this new BTK inhibitor therapy.

Glaukos has completed patient enrollment for its Phase II clinical trial of GLK-321, marking a key milestone in developing new ophthalmic therapies.

New research explores the impact of Generative AI in primary care. Can AI-driven decision support improve patient outcomes and clinical efficiency?

Bonsai Biotherapeutics, backed by Flerie, has received clinical trial approval to advance its therapeutic pipeline into human safety and efficacy testing.

Lupin receives tentative US FDA approval for Enzalutamide tablets, a key treatment for prostate cancer. Learn what this means for oncology patients.

ProQR’s AX-0810 shows promising Phase 1 results, confirming target engagement for treating cholestatic diseases. Learn about the trial's latest impact.

Zydus Lifesciences and Sunshine Holdings have launched a new joint venture to boost pharmaceutical access and medical supply chain efficiency in Sri Lanka.

A new clinical trial tests AI-run smart microcities to improve health outcomes for veterans and the homeless through predictive care and automated support.

Fosun Pharma is pivoting toward Alzheimer’s research, diversifying its global pipeline beyond oncology to target major breakthroughs in neurodegeneration.